Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection

Science Translational Medicine
Volume 13| Issue 609| 1 Sep 2021
https://www.science.org/toc/stm/current

 

Reports
Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection
Richard A. Urbanowicz et al.
05 Aug 2021
Open Access
Antibody responses to SARS-CoV-2 variants increase after two doses of BNT162b2 vaccine in both previously infected and naïve individuals.